Grail
Healthcare Services · California, United States · 51-200 Employees
View Company Info for Free
Overview
Headquarters
1525 O'brien Dr, Menlo Park, California,...Phone Number
(833) 694-2553Website
www.galleri.comRevenue
<$5 MillionIndustry
ZI Rank: 1
Signal Type
Dec
Jan
Feb
Mar
Apr
May
ZI Rank
2
1
2
2
2
1
About Grail
GRAIL, Inc. offers the Galleri test, a pioneering multi-cancer early detection blood test that identifies signals from over 50 types of cancer. This test is designed for adults at elevated risk for cancer, particularly those aged 50 and older, and aims to detect cancers before symptoms arise. The company targets patients, healthcare providers, health systems, and employers, providing resources and support for cancer screening. GRAIL collaborates with healthcare professionals to enhance cancer detection and improve patient outcomes.Explore more
Popular SearchesGrail LLCGalleri TestGalleriThe GalleriSIC Code 80,807NAICS Code 62,621Show moreSell smarter with deeper company insights.
ZoomInfo gives you access to real-time firmographics, buying signals, org charts, and decision-makers - helping your GTM teams prioritize accounts, personalize outreach with AI-driven automation, and close deals faster.
Is Grail your ideal customer? 
Let us give you the heads up on whether it's a good time to reach out
Check out if Grail is spiking on competitors!
Competitive Alert! Recent activity has been detected by your competitor Masked Content
Earning: See what the market has to say on Grail recently announced quarterly report
Check if Grail has recently received funding, and reach out quickly before it becomes old news!
Product Launch: Get notified when Grail launches new products
Funding: Get notified immidiatlly once Grail has new funding data
Grail, which may be a good buyer, showed buying intent in Masked Content Topic
Website visits: Recent activity has been detected on your website
Click to see if Grail had a recent Job posting/layoffs
Congratulate Masked Content for being promoted to Masked Content at Grail
Recommended Actions
Find VP level buyers at Grail
Find more new buyers
Compare Similar Companies to Grail
Compare insights from companies similar to Grail, focusing on performance, financial data, growth rates, and unique benchmarks to identify key industry trends and opportunities.
Revenue
Number of Employees
Type
Funding
Founded In
Grail
<$5M
51-200
Private
-
-
N/A
Company Profile Activity
Activity Insights
Grail is experiencing very low activity levels compared to other companies in the Healthcare Services sector.
What does this means?
Grail is drawing exceptional interest within the Healthcare Services industry, suggesting notable developments or strong market momentum, learn more about Grail.
Grail Tech Stack
A closer look at the technologies used by Grail
Grail News & Media
GRAIL to Present New Data From NHS-Galleri and PATHFINDER 2 at 2026 ASCO Annual Meeting
Detailed NHS-Galleri Trial Results Will be Presented as a Late-Breaking Abstract in an Oral Presentation Final PATHFINDER 2 Study Results Will be Presented as a Late-Breaking Abstract in an Oral Presentation More than 174,000 Participants Enrolled Across Both Studies, Demonstrating the...GRAIL Announces Integration of the Galleri® Test into Epic Electronic Health Record Platform to Expand Access Nationwide
Integration Will Enable Approximately 450 Health Systems to Access the Galleri Test Results Within Their Existing Patient Portal Collaboration With Epic Will Allow Clinicians to Seamlessly Order the Galleri Multi-Cancer Early Detection Test at the Point of Care MENLO PARK, Calif., April...GRAIL Reports Fourth Quarter and Full Year 2025 Financial Results
Sold More Than 185,000 Galleri® Tests in 2025, Growing U.S. Galleri Revenue 26% Year-Over-Year to $136.8 Million Completed Galleri PMA Submission to FDA Shared Topline Results from the NHS-Galleri Trial Completed Analysis of the Full 35k Participant PATHFINDER 2 Study Strong Financial...Landmark NHS-Galleri Trial Demonstrates a Substantial Reduction in Stage IV Cancer Diagnoses, Increased Stage I and II Detection of Deadly Cancers, and Four-Fold Higher Cancer Detection Rate
The Primary Endpoint of Statistically Significant Combined Stage III-IV Reduction Was Not Met, However A Favorable Trend Was Observed Over Time GRAIL Announces U.S. Sales Force Expansion Based on Strong NHS-Galleri and PATHFINDER 2 Trial Results MENLO PARK, Calif. and LONDON, Feb. 19,...
Read more news
Top Healthcare Services Companies
Top companies in New Zealand by revenue
Frequently Asked Questions Regarding Grail
Sign Up For FreeTo access detailed company insights
GRAIL, Inc. offers the Galleri test, a pioneering multi-cancer early detection blood test that identifies signals from over 50 types of cancer. This test is designed for adults at elevated risk for cancer, particularly those aged 50 and older, and aims to detect cancers before symptoms arise. The company targets patients, healthcare providers, heal... Read More
